Education
About Us
Working with TipRanks
Follow Us
Genflow Biosciences Plc (GB:GENF)
LSE:GENF
GENF Stock Chart & Stats
Day’s Range― - ―
52-Week Range0.55p - 2.30p
Previous CloseN/A
Volume13.76K
Average Volume (3M)5.18M
Market Cap
N/A
Enterprise Value7.13M
Total Cash (Recent Filing)£683.97K
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)―
Beta<0.01
Next Earnings
Apr 29, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding453,547,940
10 Day Avg. Volume6,068,285
30 Day Avg. Volume5,177,044
Financial Highlights & Ratios
PEG Ratio-0.12
Price to Book (P/B)5.76
Price to Sales (P/S)0.00
P/FCF Ratio-2.52
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Genflow Biosciences Plc News
GENF FAQ
What was Genflow Biosciences Plc’s price range in the past 12 months?
Genflow Biosciences Plc lowest share price was 0.55p and its highest was 2.30p in the past 12 months.
What is Genflow Biosciences Plc’s market cap?
Currently, no data Available
When is Genflow Biosciences Plc’s upcoming earnings report date?
Genflow Biosciences Plc’s upcoming earnings report date is Apr 29, 2026 which is in 209 days.
How were Genflow Biosciences Plc’s earnings last quarter?
Genflow Biosciences Plc released its earnings results on Sep 30, 2025. The company reported -0.002p earnings per share for the quarter, missing the consensus estimate of N/A by -0.002p.
Is Genflow Biosciences Plc overvalued?
According to Wall Street analysts Genflow Biosciences Plc’s price is currently Overvalued.
Does Genflow Biosciences Plc pay dividends?
Genflow Biosciences Plc does not currently pay dividends.
What is Genflow Biosciences Plc’s EPS estimate?
Genflow Biosciences Plc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Genflow Biosciences Plc have?
Genflow Biosciences Plc has 453,547,940 shares outstanding.
What happened to Genflow Biosciences Plc’s price movement after its last earnings report?
Genflow Biosciences Plc reported an EPS of -0.002p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.226%.
Which hedge fund is a major shareholder of Genflow Biosciences Plc?
Currently, no hedge funds are holding shares in GB:GENF
Company Description
Genflow Biosciences Plc
Genflow Biosciences plc operates as a biotechnology company that focuses on developing biological interventions aimed at tackling the effects of ageing, slowing or halting the ageing process, and reducing the incidence of age-related diseases with increase in health span. Its lead compound is GF-1002, a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion. The company is also developing GF-3001, a topical delivery of SIRT6 to the skin; and GF-4001, a non-human pipeline anti-aging for veterinary use. The company was incorporated in 2021 and is headquartered in London, the United Kingdom.
Technical Analysis
Evgen Pharma
―
Cizzle Biotechnology Holdings PLC
―
Physiomics
―
Sareum Holdings
―
ValiRx plc
―
Options Prices
Currently, No data available
---